Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Gene therapy symbols : NVS save search
Voyager Therapeutics Announces License Option Agreement with Novartis for Target-Specific Access to Next-Generation TRACER™ AAV Capsids for Gene Therapy Programs
Published: 2022-03-08 (Crawled : 07:00) - globenewswire.com
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
|
| O: -4.98%
H: 0.0%
C: 0.0%
VYGR | News | $7.645 0.99% 0.98% 370K
|
Health Technology
|
| O: 31.15%
H: 19.58%
C: 9.17%
trace novartis aav capsids gene therapy program license therapeutics therapy
Worldwide Gene Therapy Industry to 2027 - Players Include Amgen, Biogen and Novartis Among Others
Published: 2022-03-04 (Crawled : 21:00) - prnewswire.com
QURE | $4.755 -1.35% -1.37% 460K
|
Health Technology
| Email alert
Add to watchlist
ABEO | News | $3.395 -53.87% -116.79% 5.5M
|
Health Technology
| Email alert
Add to watchlist
NVSEF | News | $95.11 6.88% 490
|
Health Technology
| Email alert
Add to watchlist
BIIB | $193.18 -0.48% -0.48% 1.4M
|
Health Technology
| Email alert
Add to watchlist
ORTX | $16.7 0.0% 370K
|
Health Technology
| Email alert
Add to watchlist
ALPMY | News | $9.53 -1.11% 690K
|
Manufacturing
| Email alert
Add to watchlist
AMGN | News | $273.69 0.66% 0.65% 2.5M
|
Health Technology
| Email alert
Add to watchlist
ADAP | $1.12 10.89% 9.82% 1.1M
|
Health Technology
| Email alert
Add to watchlist
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
| Email alert
Add to watchlist
ALPMF | News | $9.75 43.47% 200
|
Health Technology
| Email alert
Add to watchlist
novartis gene therapy therapy
Novartis to acquire Gyroscope Therapeutics, adding a one-time gene therapy that could transform care for geographic atrophy, a leading cause of blindness
Published: 2021-12-22 (Crawled : 12:30) - globenewswire.com
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
|
| O: -0.55%
H: 0.99%
C: 0.92%
novartis gene therapy therapeutics therapy
Cell And Gene Therapy Manufacturing Market Size Worth $57.4 Billion By 2028: Grand View Research, Inc.
Published: 2021-09-01 (Crawled : 09:00) - prnewswire.com
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
|
| O: 0.28%
H: 0.35%
C: 0.0%
gene therapy therapy research gene therapies
Asia-Pacific Gene Therapy Markets, 2021-2030 - Product Launches and Grants / Outsourcing of Vector and Gene Therapy Manufacturing
Published: 2021-08-26 (Crawled : 18:00) - prnewswire.com
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
|
| O: 0.24%
H: 0.0%
C: 0.0%
AMGN | News | $273.69 0.66% 0.65% 2.5M
|
Health Technology
|
| O: 0.34%
H: 1.41%
C: 0.25%
gene therapy therapy gene therapies grant
Global Regenerative Medicine Markets, 2021-2029: Focus on Cell Therapy, Gene Therapy, Tissue Engineering, Small Molecule & Biologics
Published: 2021-08-18 (Crawled : 17:00) - prnewswire.com
SYK | $334.91 2.21% -4.72% 1.4M
|
Health Technology
|
| O: -0.04%
H: 0.04%
C: -1.45%
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
|
| O: -0.43%
H: 0.05%
C: -1.36%
MDT | $81.29 0.89% 0.0% 5.2M
|
Health Technology
|
| O: 0.03%
H: 0.28%
C: -1.12%
ABBV | News | $169.54 0.98% -0.91% 4.1M
|
Health Technology
|
| O: -0.41%
H: 0.63%
C: -1.58%
MMM | $93.0 0.41% -0.4% 3.7M
|
Producer Manufacturing
|
| O: -0.49%
H: 0.12%
C: -1.04%
AMGN | News | $273.69 0.66% 0.65% 2.5M
|
Health Technology
|
| O: -0.29%
H: 0.35%
C: -1.6%
gene therapy therapy gene therapies
Global $57.4 Billion Cell And Gene Therapy Manufacturing Market to 2028 - Rising Pressure on Drug Developers/Manufacturers to Meet the Growing Market Demand
Published: 2021-07-29 (Crawled : 22:00) - prnewswire.com
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
|
| O: 0.59%
H: 0.0%
C: 0.0%
gene therapy therapy growing drug gene therapies
Global Gene Therapy Markets Report 2021-2030: Antigen, Cytokine, Suicide Gene, Viral Vector, Non-Viral Vector, Oncological, Rare Diseases, Cardiovascular, Neurological Disorders, Infectious Diseases
Published: 2021-06-25 (Crawled : 11:00) - prnewswire.com
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
|
| O: 0.16%
H: 0.09%
C: -0.13%
QURE | $4.755 -1.35% -1.37% 460K
|
Health Technology
|
| O: 0.73%
H: 2.08%
C: 2.01%
SRPT | $117.065 0.09% 0.09% 440K
|
Health Technology
|
| O: 0.15%
H: 1.37%
C: 0.75%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 0.55%
H: 0.68%
C: 0.57%
CLLS | News | $2.535 -3.98% -4.14% 47K
|
Health Technology
|
| O: -0.45%
H: 1.88%
C: 1.3%
BLUE | $0.9739 2.13% 2.08% 4.8M
|
Health Technology
|
| O: 0.53%
H: 0.0%
C: -4.89%
AGTC | News | $0.3936 1.23% 0.0%
|
Health Technology
|
| O: -1.97%
H: 0.24%
C: -2.72%
disease neurological cardiovascular infectious disease gene therapy therapy cardio gene therapies rare
APAC Gene Therapy Market Size To Be $6,931.5 Million by 2030 says P&S Intelligence
Published: 2021-06-02 (Crawled : 09:00) - prnewswire.com
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
|
| O: 0.85%
H: 0.37%
C: 0.02%
AMGN | News | $273.69 0.66% 0.65% 2.5M
|
Health Technology
|
| O: 0.57%
H: 0.76%
C: 0.11%
gene therapy therapy gene therapies
Cell and Gene Therapy Drug Delivery Devices Market, 2030 - Market Opportunities in the Strong Pipeline of Cell and Gene Therapies
Published: 2021-03-30 (Crawled : 22:00) - prnewswire.com
PFE | News A | $26.32 0.23% 0.0% 24M
|
Health Technology
|
| O: 0.11%
H: 0.77%
C: 0.22%
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
|
| O: -1.55%
H: 0.51%
C: -0.22%
BDX | $234.36 0.21% 0.0% 800K
|
Health Technology
|
| O: -0.01%
H: 0.25%
C: -0.82%
VCEL | $46.38 2.2% 2.16% 360K
|
Health Technology
|
| O: 0.74%
H: 5.83%
C: 4.75%
QURE | $4.755 -1.35% -1.37% 460K
|
Health Technology
|
| O: -0.81%
H: 4.45%
C: 2.03%
ORTX | $16.7 0.0% 370K
|
Health Technology
|
| O: -0.7%
H: 4.08%
C: 2.25%
BLUE | $0.9739 2.13% 2.08% 4.8M
|
Health Technology
|
| O: 0.66%
H: 5.38%
C: 4.65%
AMGN | News | $273.69 0.66% 0.65% 2.5M
|
Health Technology
|
| O: -0.21%
H: 0.29%
C: -0.17%
gene therapies gene therapy therapy drug device drug delivery liver
Global Cell and Gene Therapy Market Report 2021-2027: Market Opportunities in Drug Approvals and Strong Pipeline & Increasing Number of Mergers and Acquisitions
Published: 2021-03-08 (Crawled : 13:14) - prnewswire.com
PFE | News A | $26.32 0.23% 0.0% 24M
|
Health Technology
|
| O: 0.26%
H: 1.13%
C: -0.38%
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
|
| O: -0.02%
H: 0.89%
C: -0.31%
ORGO | $2.985 0.51% 0.5% 630K
|
Finance
|
| O: 1.86%
H: 1.82%
C: -2.21%
AMGN | News | $273.69 0.66% 0.65% 2.5M
|
Health Technology
|
| O: 0.15%
H: 1.81%
C: -0.12%
acquisition gene therapy therapy acquisitions drug merge approval gene therapies
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News M | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.